메뉴 건너뛰기




Volumn 2, Issue 1, 2010, Pages 185-198

Mitochondrial therapy for parkinson's disease: Neuroprotective pharmaconutrition may be disease-modifying

Author keywords

Apoptosis; Creatine; Inflammation; Mitochondria; Parkinson's disease; Polyunsaturated omega 3 fatty acids; Reactive oxygen species; Ubiquinone; Vitamin D

Indexed keywords

CALCIUM; COLECALCIFEROL; CREATINE; DOCOSAHEXAENOIC ACID; ERGOCALCIFEROL; MINOCYCLINE; OMEGA 3 FATTY ACID; PARKIN; PLACEBO; REACTIVE OXYGEN METABOLITE; UBIDECARENONE; VITAMIN D;

EID: 78650743609     PISSN: None     EISSN: 11791438     Source Type: Book Series    
DOI: 10.2147/CPAA.S12082     Document Type: Review
Times cited : (10)

References (148)
  • 1
    • 0141741347 scopus 로고    scopus 로고
    • Parkinson's disease: Mechanisms and models
    • Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models. Neuron. 2003;39:889-909.
    • (2003) Neuron , vol.39 , pp. 889-909
    • Dauer, W.1    Przedborski, S.2
  • 3
    • 0038632257 scopus 로고    scopus 로고
    • Clinical characteristics of the alpha- synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece
    • Papapetropoulos S, Ellul J, Paschalis C, Athanassiadou A, Papadimitriou A, Papapetropoulos T. Clinical characteristics of the alpha- synuclein mutation (G209A)-associated Parkinson's disease in comparison with other forms of familial Parkinson's disease in Greece. Eur J Neurol. 2003;10:281.
    • (2003) Eur J Neurol , vol.10 , pp. 281
    • Papapetropoulos, S.1    Ellul, J.2    Paschalis, C.3    Athanassiadou, A.4    Papadimitriou, A.5    Papapetropoulos, T.6
  • 4
    • 55949092886 scopus 로고    scopus 로고
    • Alpha-synuclein misfolding and neurodegenerative diseases
    • Uversky VN. Alpha-synuclein misfolding and neurodegenerative diseases. Curr Protein Pept Sci. 2008;9:507-540.
    • (2008) Curr Protein Pept Sci , vol.9 , pp. 507-540
    • Uversky, V.N.1
  • 5
    • 33846996820 scopus 로고    scopus 로고
    • Pesticide exposure and self-reported Parkinson's disease in the agricultural health study
    • Kamel F, Tanner C, Umbach D, et al. Pesticide exposure and self-reported Parkinson's disease in the agricultural health study. Am J Epidemiol. 2007;165:364-374.
    • (2007) Am J Epidemiol , vol.165 , pp. 364-374
    • Kamel, F.1    Tanner, C.2    Umbach, D.3
  • 6
    • 42449155102 scopus 로고    scopus 로고
    • Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
    • Hancock DB, Martin ER, Mayhew GM, et al. Pesticide exposure and risk of Parkinson's disease: A family-based case-control study. BMC Neurol. 2008;8:6.
    • (2008) BMC Neurol , vol.8 , pp. 6
    • Hancock, D.B.1    Martin, E.R.2    Mayhew, G.M.3
  • 7
    • 63649095770 scopus 로고    scopus 로고
    • Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California
    • Costello S, Cockburn M, Bronstein J, Zhang X, Ritz B. Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the Central Valley of California. Am J Epidemiol. 2009;169: 919-926.
    • (2009) Am J Epidemiol , vol.169 , pp. 919-926
    • Costello, S.1    Cockburn, M.2    Bronstein, J.3    Zhang, X.4    Ritz, B.5
  • 8
    • 21144447013 scopus 로고    scopus 로고
    • Searching for a relationship between manganese and welding and Parkinson's disease
    • Jankovic J. Searching for a relationship between manganese and welding and Parkinson's disease. Neurology. 2005;12: 2021-2028.
    • (2005) Neurology , vol.12 , pp. 2021-2028
    • Jankovic, J.1
  • 10
    • 71049137290 scopus 로고    scopus 로고
    • Identification of L-ferritin in neuromelanin granules of the human substantia nigra: A targeted proteomics approach
    • Tribl F, Asan E, Arzberger T, et al. Identification of L-ferritin in neuromelanin granules of the human substantia nigra: A targeted proteomics approach. Mol Cell Proteomics. 2009; 8: 1832.
    • (2009) Mol Cell Proteomics , vol.8 , pp. 1832
    • Tribl, F.1    Asan, E.2    Arzberger, T.3
  • 11
    • 24944450803 scopus 로고    scopus 로고
    • Subcellular proteomics of neuromelanin granules isolated from the human brain
    • Tribil F, Gerlach M, Marcus K, et al. Subcellular proteomics of neu- romelanin granules isolated from the human brain. Mol Cell Proteomics. 2005; 4: 945-957.
    • (2005) Mol Cell Proteomics , vol.4 , pp. 945-957
    • Tribil, F.1    Gerlach, M.2    Marcus, K.3
  • 12
    • 33646948530 scopus 로고    scopus 로고
    • Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled
    • Keeney PM, Xie J, Capaldi RA, Bennett JP Jr. Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 2006; 26: 5256-5264.
    • (2006) J Neurosci , vol.26 , pp. 5256-5264
    • Keeney, P.M.1    Xie, J.2    Capaldi, R.A.3    Bennett Jr., J.P.4
  • 13
    • 45449100897 scopus 로고    scopus 로고
    • Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background
    • Esteves AR, Domingues AF, Ferreira IL, et al. Mitochondrial function in Parkinson's disease cybrids containing an nt2 neuron-like nuclear background. Mitochondrion. 2008; 8: 219-228.
    • (2008) Mitochondrion , vol.8 , pp. 219-228
    • Esteves, A.R.1    Domingues, A.F.2    Ferreira, I.L.3
  • 14
    • 57349130113 scopus 로고    scopus 로고
    • A mitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease
    • Khusnutdinova E, Gilyazova I, Ruiz-Pesini E, et al. A mitochondrial etiology of neurodegenerative diseases: Evidence from Parkinson's disease. Ann N Y Acad Sci. 2008; 1147:1-20.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 1-20
    • Khusnutdinova, E.1    Gilyazova, I.2    Ruiz-Pesini, E.3
  • 15
    • 57649210194 scopus 로고    scopus 로고
    • Impairing the mitochondrial fission and fusion balance: A new mechanism of neurodegeneration
    • Knott AB, Bossy-Wetzel E. Impairing the mitochondrial fission and fusion balance: A new mechanism of neurodegeneration. Ann N Y Acad Sci. 2008; 1147:283-292.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 283-292
    • Knott, A.B.1    Bossy-Wetzel, E.2
  • 16
    • 78650717751 scopus 로고    scopus 로고
    • Functional implications
    • Mannella C. Functional implications. Ann N Y Acad Sci. 2008; 1147: 147-179.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 147-179
    • Mannella, C.1
  • 17
    • 57749101148 scopus 로고    scopus 로고
    • Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease
    • Henchcliffe C, Shungu DC, Mao X, et al. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson's disease. Ann N Y Acad Sci. 2008; 1147: 206-220.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 206-220
    • Henchcliffe, C.1    Shungu, D.C.2    Mao, X.3
  • 18
    • 34247366072 scopus 로고    scopus 로고
    • Inflammation as a causative factor in the aetiology of Parkinson's disease
    • Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease. Br J Pharm. 2007; 50: 963-976.
    • (2007) Br J Pharm , vol.50 , pp. 963-976
    • Whitton, P.S.1
  • 20
    • 43549111605 scopus 로고    scopus 로고
    • Inflammation in Parkinson's disease: An update
    • Smith PF. Inflammation in Parkinson's disease: An update. Curr Opin Invest Drug. 2008;9: 478-484.
    • (2008) Curr Opin Invest Drug , vol.9 , pp. 478-484
    • Smith, P.F.1
  • 21
    • 44149103168 scopus 로고    scopus 로고
    • Neuroinflammation and peripheral immune infiltration in Parkinson's disease: An autoimmune hypothesis
    • Monahan AJ, Warren M, Carvey PM. Neuroinflammation and peripheral immune infiltration in Parkinson's disease: An autoimmune hypothesis. Cell Transplant. 2008;4:363-372.
    • (2008) Cell Transplant , vol.4 , pp. 363-372
    • Monahan, A.J.1    Warren, M.2    Carvey, P.M.3
  • 22
    • 34248400478 scopus 로고    scopus 로고
    • Therapeutic approaches to inflammation in neurodegenerative disease
    • Klegeris A, McGeer EG, McGeer P. Therapeutic approaches to inflammation in neurodegenerative disease. Curr Opin Neurol. 2007; 20:351-357.
    • (2007) Curr Opin Neurol , vol.20 , pp. 351-357
    • Klegeris, A.1    McGeer, E.G.2    McGeer, P.3
  • 23
    • 16344386871 scopus 로고    scopus 로고
    • The role of microglia in paraquat-induced dopaminergic neurotoxicity
    • Wu XF, Block ML, Zhang W, et al. The role of microglia in paraquat-induced dopaminergic neurotoxicity. Antioxid Redox Signal. 2005;7:654-661.
    • (2005) Antioxid Redox Signal , vol.7 , pp. 654-661
    • Wu, X.F.1    Block, M.L.2    Zhang, W.3
  • 24
    • 33749570292 scopus 로고    scopus 로고
    • Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease
    • Anderson JP, Walker DE, Goldstein JM, et al. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem. 2006; 281: 29739-29752.
    • (2006) J Biol Chem , vol.281 , pp. 29739-29752
    • Anderson, J.P.1    Walker, D.E.2    Goldstein, J.M.3
  • 25
    • 57649233172 scopus 로고    scopus 로고
    • Mitochondria-targeted anti- oxidants in the treatment of disease
    • Smith RA, Adlam VJ, Blaikie FH, et al. Mitochondria-targeted anti- oxidants in the treatment of disease. Ann N Y Acad Sci. 2008;1147: 105-111.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 105-111
    • Smith, R.A.1    Adlam, V.J.2    Blaikie, F.H.3
  • 26
    • 34248995257 scopus 로고    scopus 로고
    • The action potential in mammalian central neurons
    • Bean BP. The action potential in mammalian central neurons. Nat Rev Neurosci. 2007; 8: 451-465.
    • (2007) Nat Rev Neurosci , vol.8 , pp. 451-465
    • Bean, B.P.1
  • 27
    • 34347359673 scopus 로고    scopus 로고
    • 'Rejuvenation' protects neurons in mouse models of Parkinson's disease
    • Chan CS, Guzman JN, Ilijic E, et al. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature. 2007;447: 1081-1086.
    • (2007) Nature , vol.447 , pp. 1081-1086
    • Chan, C.S.1    Guzman, J.N.2    Ilijic, E.3
  • 28
    • 61449156563 scopus 로고    scopus 로고
    • Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology
    • Schwartz A, Ciechanover A. Targeting proteins for destruction by the ubiquitin system: Implications for human pathobiology. Annu Rev Pharmacol Toxicol. 2009;49:73-96.
    • (2009) Annu Rev Pharmacol Toxicol , vol.49 , pp. 73-96
    • Schwartz, A.1    Ciechanover, A.2
  • 29
    • 40549090917 scopus 로고    scopus 로고
    • Ubiquitination of α-synuclein by Siah-1 promotes α-synuclein aggregation and apoptotic cell death
    • Lee JT, Wheeler TC, Li L, Chin LS. Ubiquitination of α-synuclein by Siah-1 promotes α-synuclein aggregation and apoptotic cell death. Hum Mol Genet. 2008;17:906-917.
    • (2008) Hum Mol Genet , vol.17 , pp. 906-917
    • Lee, J.T.1    Wheeler, T.C.2    Li, L.3    Chin, L.S.4
  • 30
    • 2442645048 scopus 로고    scopus 로고
    • Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover
    • Sullivan PG, Dragicevic NB, Deng J-H, et al. Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem. 2004;279:20699-20707.
    • (2004) J Biol Chem , vol.279 , pp. 20699-20707
    • Sullivan, P.G.1    Dragicevic, N.B.2    Deng, J.-H.3
  • 31
    • 0021225314 scopus 로고
    • Repression of L-arginine: Glycine amidinotransferase synthesis by creatine at a pretranslational level
    • McGuire DM, Gross MD, Van Pilsum JF, Towle HC. Repression of L-arginine: glycine amidinotransferase synthesis by creatine at a pretranslational level. J Biol Chem. 1984;259:12034-12038.
    • (1984) J Biol Chem , vol.259 , pp. 12034-12038
    • McGuire, D.M.1    Gross, M.D.2    Van Pilsum, J.F.3    Towle, H.C.4
  • 32
    • 60849116967 scopus 로고    scopus 로고
    • Creatine synthesis: Hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo
    • Da Silva RP, Nissim I, Brosnan ME, Brosnan JT. Creatine synthesis: Hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo. Am J Physiol Endocrinol Metab. 2009; 296: E256-E261.
    • (2009) Am J Physiol Endocrinol Metab , vol.296
    • da Silva, R.P.1    Nissim, I.2    Brosnan, M.E.3    Brosnan, J.T.4
  • 33
    • 67649995770 scopus 로고    scopus 로고
    • Creatine synthesis is a major metabolic process in neonatal piglets and has important implications for amino acid metabolism and methyl balance
    • Brosnan JT, Wijekoon EP, Warford-Woolgar L, et al. Creatine synthesis is a major metabolic process in neonatal piglets and has important implications for amino acid metabolism and methyl balance. J Nutr. 2009;139:1292-1297.
    • (2009) J Nutr , vol.139 , pp. 1292-1297
    • Brosnan, J.T.1    Wijekoon, E.P.2    Warford-Woolgar, L.3
  • 34
    • 0346816570 scopus 로고    scopus 로고
    • Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance
    • Rawson ES, Volek JS. Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. J Strength Cond Res. 2003;4:822-831.
    • (2003) J Strength Cond Res , vol.4 , pp. 822-831
    • Rawson, E.S.1    Volek, J.S.2
  • 35
    • 38949116663 scopus 로고    scopus 로고
    • Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle
    • Deldicque L, Atherton P, Patel R, et al. Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle. J Appl Physiol. 2008; 2:371-378.
    • (2008) J Appl Physiol , vol.2 , pp. 371-378
    • Deldicque, L.1    Atherton, P.2    Patel, R.3
  • 36
    • 67649246832 scopus 로고    scopus 로고
    • Creatine supplementation enhances muscle force recovery after eccentrically- induced muscle damage in healthy individuals
    • Cooke MB, Rybalka E, Williams AD, Cribb PJ, Hayes AJ. Creatine supplementation enhances muscle force recovery after eccentrically- induced muscle damage in healthy individuals. Int Soc Sports Nutr. 2009; 6:13.
    • (2009) Int Soc Sports Nutr , vol.6 , pp. 13
    • Cooke, M.B.1    Rybalka, E.2    Williams, A.D.3    Cribb, P.J.4    Hayes, A.J.5
  • 37
    • 0038381490 scopus 로고    scopus 로고
    • Inhibi- tion of the mitochondrial permeability transition by creatine kinase substrates
    • Requirement for microcompartmentation
    • Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T. Inhibi- tion of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem. 2003; 278:17760-17766.
    • (2003) J Biol Chem , vol.278 , pp. 17760-17766
    • Dolder, M.1    Walzel, B.2    Speer, O.3    Schlattner, U.4    Wallimann, T.5
  • 38
    • 0035002174 scopus 로고    scopus 로고
    • Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders
    • Tarnopolsky MA, Beal MF. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol. 2001;49:561-574.
    • (2001) Ann Neurol , vol.49 , pp. 561-574
    • Tarnopolsky, M.A.1    Beal, M.F.2
  • 39
    • 0032854736 scopus 로고    scopus 로고
    • Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes
    • Dai W, Vinnakota S, Qian X, Kunze DL, Sarkar HK. Molecular characterization of the human CRT-1 creatine transporter expressed in Xenopus oocytes. Arch Biochem Biophys. 1999;361:75-84.
    • (1999) Arch Biochem Biophys , vol.361 , pp. 75-84
    • Dai, W.1    Vinnakota, S.2    Qian, X.3    Kunze, D.L.4    Sarkar, H.K.5
  • 40
    • 0343022262 scopus 로고    scopus 로고
    • Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study
    • Walter MC, Lochmuller H, Reilich P, et al. Creatine monohydrate in muscular dystrophies: A double-blind, placebo-controlled clinical study. Neurology. 2000;54:1848-1850.
    • (2000) Neurology , vol.54 , pp. 1848-1850
    • Walter, M.C.1    Lochmuller, H.2    Reilich, P.3
  • 41
    • 0033541016 scopus 로고    scopus 로고
    • Creatine monohydrate increases strength in patients with neuromuscular disease
    • Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology. 1999;52:854-857.
    • (1999) Neurology , vol.52 , pp. 854-857
    • Tarnopolsky, M.1    Martin, J.2
  • 42
    • 0031977802 scopus 로고    scopus 로고
    • The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure
    • Andrews R, Greenhaff P, Curtis S, Perry A, Cowley AJ. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur Heart J. 1998;19:617-622.
    • (1998) Eur Heart J , vol.19 , pp. 617-622
    • Andrews, R.1    Greenhaff, P.2    Curtis, S.3    Perry, A.4    Cowley, A.J.5
  • 43
    • 0028597053 scopus 로고
    • Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - effects of long-term dietary supplementation
    • Broqvist M, Arnqvist H, Dahlstrom U, Larsson J, Nylander E, Permert J. Nutritional assessment and muscle energy metabolism in severe chronic congestive heart failure - effects of long-term dietary supplementation. Eur Heart J. 1994;15:1641-1650.
    • (1994) Eur Heart J , vol.15 , pp. 1641-1650
    • Broqvist, M.1    Arnqvist, H.2    Dahlstrom, U.3    Larsson, J.4    Nylander, E.5    Permert, J.6
  • 46
    • 68249158146 scopus 로고    scopus 로고
    • Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance
    • Johnston APW, Burke DG, MacNeil LG, Candow DG. Effect of creatine supplementation during cast-induced immobilization on the preservation of muscle mass, strength, and endurance. J Strength Cond Res. 2009;23:116-120.
    • (2009) J Strength Cond Res , vol.23 , pp. 116-120
    • Johnston, A.P.W.1    Burke, D.G.2    Macneil, L.G.3    Candow, D.G.4
  • 47
    • 12244277899 scopus 로고    scopus 로고
    • Creatine depletion in a new case with AGAT deficiency: Clinical and genetic study in a large pedigree
    • Battini R, Leuzzi V, Carducci C, et al. Creatine depletion in a new case with AGAT deficiency: Clinical and genetic study in a large pedigree. Molec Genet Metab. 2002;77:326-331.
    • (2002) Molec Genet Metab , vol.77 , pp. 326-331
    • Battini, R.1    Leuzzi, V.2    Carducci, C.3
  • 48
    • 0037306564 scopus 로고    scopus 로고
    • Creatine deficiency syndromes
    • Schulze A. Creatine deficiency syndromes. Mol Cell Biochem. 2003;244:143-150.
    • (2003) Mol Cell Biochem , vol.244 , pp. 143-150
    • Schulze, A.1
  • 49
    • 0142074341 scopus 로고    scopus 로고
    • Oral creatine mono- hydrate supplementation improves brain performance: A double- blind, placebo-controlled, cross-over trial
    • Rae C, Digney AL, McEwan SR, Bates TC. Oral creatine mono- hydrate supplementation improves brain performance: A double- blind, placebo-controlled, cross-over trial. Proc Biol Sci. 2003;270: 2147-2150.
    • (2003) Proc Biol Sci , vol.270 , pp. 2147-2150
    • Rae, C.1    Digney, A.L.2    McEwan, S.R.3    Bates, T.C.4
  • 50
    • 33344471016 scopus 로고    scopus 로고
    • Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol
    • McMorris T, Harris RC, Swain J, et al. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl). 2006;185:93-103.
    • (2006) Psychopharmacology (Berl) , vol.185 , pp. 93-103
    • McMorris, T.1    Harris, R.C.2    Swain, J.3
  • 52
    • 0042804970 scopus 로고    scopus 로고
    • Creatine diet supplement for spinal cord injury: Influences on functional recovery and tissue sparing in rats
    • Rabchevsky AG, Sullivan PG, Fugaccia I, Scheff SW. Creatine diet supplement for spinal cord injury: Influences on functional recovery and tissue sparing in rats. J Neurotrauma. 2003;20:659-669
    • (2003) J Neurotrauma , vol.20 , pp. 659-669
    • Rabchevsky, A.G.1    Sullivan, P.G.2    Fugaccia, I.3    Scheff, S.W.4
  • 53
    • 0036711579 scopus 로고    scopus 로고
    • Protective effects of oral creatine supplementation on spinal cord injury in rats
    • Hausmann ON, Fouad K, Wallimann T, Schwab ME. Protective effects of oral creatine supplementation on spinal cord injury in rats. Spinal Cord. 2002;40:449-456.
    • (2002) Spinal Cord , vol.40 , pp. 449-456
    • Hausmann, O.N.1    Fouad, K.2    Wallimann, T.3    Schwab, M.E.4
  • 54
    • 0033767740 scopus 로고    scopus 로고
    • Dietary supplement creatine protects against traumatic brain injury
    • Sullivan PG, Geiger JD, Mattson MP, Scheff SW. Dietary supplement creatine protects against traumatic brain injury. Ann Neurol. 2000;48:723-729.
    • (2000) Ann Neurol , vol.48 , pp. 723-729
    • Sullivan, P.G.1    Geiger, J.D.2    Mattson, M.P.3    Scheff, S.W.4
  • 55
    • 0036949481 scopus 로고    scopus 로고
    • Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia
    • Adcock KH, Nedelcu J, Loenneker T, Martin E, Willimann T, Wagner BP. Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia. Dev Neurosci. 2002;24:382-388.
    • (2002) Dev Neurosci , vol.24 , pp. 382-388
    • Adcock, K.H.1    Nedelcu, J.2    Loenneker, T.3    Martin, E.4    Willimann, T.5    Wagner, B.P.6
  • 56
    • 3042796442 scopus 로고    scopus 로고
    • Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice
    • Zhu S, Li M, Figueroa BE, et al. Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice. J Neurosci. 2004;24:5909-5912.
    • (2004) J Neurosci , vol.24 , pp. 5909-5912
    • Zhu, S.1    Li, M.2    Figueroa, B.E.3
  • 57
    • 33847229764 scopus 로고    scopus 로고
    • Improved reperfusion and neuroprotection by creatine in a mouse model of stroke
    • Prass K, Royl G, Lindauer U, et al. Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J Cereb Blood Flow Metab. 2007;27:452-459.
    • (2007) J Cereb Blood Flow Metab , vol.27 , pp. 452-459
    • Prass, K.1    Royl, G.2    Lindauer, U.3
  • 58
    • 57649171115 scopus 로고    scopus 로고
    • Mitochondrial approaches for neuroprotection
    • Chaturvedi RK, Beal MF. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci. 2008;1147:395-412.
    • (2008) Ann N Y Acad Sci , vol.1147 , pp. 395-412
    • Chaturvedi, R.K.1    Beal, M.F.2
  • 59
    • 0034208612 scopus 로고    scopus 로고
    • Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse
    • Ikeda K, Iwasaki Y, Kinoshita M. Oral administration of creatine monohydrate retards progression of motor neuron disease in the wobbler mouse. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:207-212.
    • (2000) Amyotroph Lateral Scler Other Motor Neuron Disord , vol.1 , pp. 207-212
    • Ikeda, K.1    Iwasaki, Y.2    Kinoshita, M.3
  • 60
    • 0038115294 scopus 로고    scopus 로고
    • Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice
    • Dedeoglu A, Kubilus JK, Yang L, et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice. J Neurochem. 2008;85:1359-1367.
    • (2008) J Neurochem , vol.85 , pp. 1359-1367
    • Dedeoglu, A.1    Kubilus, J.K.2    Yang, L.3
  • 61
    • 27344447235 scopus 로고    scopus 로고
    • The therapeutic role of creatine in Huntington's disease
    • Ryu H, Rosas HD, Hersch SM, Ferrante RJ. The therapeutic role of creatine in Huntington's disease. Pharmacol Ther. 2005;108:193-207.
    • (2005) Pharmacol Ther , vol.108 , pp. 193-207
    • Ryu, H.1    Rosas, H.D.2    Hersch, S.M.3    Ferrante, R.J.4
  • 62
    • 33644927838 scopus 로고    scopus 로고
    • Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 9OH2'dG
    • Hersch SM, Gevorkian S, Marder K, et al. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 9OH2'dG. Neurology. 2006;66:250-262.
    • (2006) Neurology , vol.66 , pp. 250-262
    • Hersch, S.M.1    Gevorkian, S.2    Marder, K.3
  • 63
    • 0032914740 scopus 로고    scopus 로고
    • Creatine and cyclocreatine attenuate MPTP neurotoxicity
    • Matthews RT, Ferrante RJ, Klivenyi P, et al. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol. 1999;157:142-149.
    • (1999) Exp Neurol , vol.157 , pp. 142-149
    • Matthews, R.T.1    Ferrante, R.J.2    Klivenyi, P.3
  • 65
    • 3142514196 scopus 로고    scopus 로고
    • Oxidative stress in neurodegeneration: Cause or consequence?
    • Anderson JK. Oxidative stress in neurodegeneration: Cause or consequence? Nat Rev Neurosci. 2004;5:S18-S25.
    • (2004) Nat Rev Neurosci , vol.5
    • Anderson, J.K.1
  • 66
    • 12844260125 scopus 로고    scopus 로고
    • Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane
    • Speer O, Back N, Buerklen T, et al. Octameric mitochondrial creatine kinase induces and stabilizes contact sites between the inner and outer membrane. Biochem J. 2005;85:445-450.
    • (2005) Biochem J , vol.85 , pp. 445-450
    • Speer, O.1    Back, N.2    Buerklen, T.3
  • 68
    • 34250308322 scopus 로고    scopus 로고
    • Apoptosis
    • A review of programmed cell death
    • Elmore S. Apoptosis. A review of programmed cell death. Toxicol Pathol. 2007;35:495-516.
    • (2007) Toxicol Pathol , vol.35 , pp. 495-516
    • Elmore, S.1
  • 69
    • 68149131973 scopus 로고    scopus 로고
    • Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway
    • Trisciuoglio L, Emilio Bianchi ME. Several nuclear events during apoptosis depend on caspase-3 activation but do not constitute a common pathway. PLoS ONE. 2009;4:e6234.
    • (2009) PLoS ONE , vol.4
    • Trisciuoglio, L.1    Emilio, B.M.E.2
  • 70
    • 0027300802 scopus 로고
    • Functional coupling between sarcoplasmic reticulum-bound creatine kinase and Ca(2+)-ATPase
    • Korge P, Byrd SK, Campbell KB. Functional coupling between sarcoplasmic reticulum-bound creatine kinase and Ca(2+)-ATPase. Eur J Biochem. 1993;3:973-980.
    • (1993) Eur J Biochem , vol.3 , pp. 973-980
    • Korge, P.1    Byrd, S.K.2    Campbell, K.B.3
  • 71
    • 1842471937 scopus 로고    scopus 로고
    • Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase
    • Klivenyi P, Calingasan NY, Starkov A, et al. Neuroprotective mechanisms of creatine occur in the absence of mitochondrial creatine kinase. Neurobiol Dis. 2004;15:610-617.
    • (2004) Neurobiol Dis , vol.15 , pp. 610-617
    • Klivenyi, P.1    Calingasan, N.Y.2    Starkov, A.3
  • 72
    • 33645894705 scopus 로고    scopus 로고
    • A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease
    • NINDS NET-PD Investigators
    • NINDS NET-PD Investigators. A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease. Neurology. 2006;66:664-671.
    • (2006) Neurology , vol.66 , pp. 664-671
  • 73
    • 0027530638 scopus 로고
    • Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease
    • The Parkinson Study Group
    • The Parkinson Study Group. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. N Engl J Med. 1993;28:176-183.
    • (1993) N Engl J Med , vol.28 , pp. 176-183
  • 75
    • 34147177574 scopus 로고    scopus 로고
    • Clinical research
    • Testing a novel strategy against Parkinson's disease
    • Couzin J. Clinical research. Testing a novel strategy against Parkinson's disease. Science. 2007;315:1778.
    • (2007) Science , vol.315 , pp. 1778
    • Couzin, J.1
  • 76
    • 33846948238 scopus 로고    scopus 로고
    • Resistance training with creatine monohydrate improve upper-body strength in patients with Parkinson disease: A randomized trial
    • Hass CJ, Collins MA, Juncos JL. Resistance training with creatine monohydrate improve upper-body strength in patients with Parkinson disease: A randomized trial. Neurorehabil Neural Repair. 2007; 21: 107-115.
    • (2007) Neurorehabil Neural Repair , vol.21 , pp. 107-115
    • Hass, C.J.1    Collins, M.A.2    Juncos, J.L.3
  • 77
    • 0031690802 scopus 로고    scopus 로고
    • Biochemical and clinical consequences of inhibiting coenzyme Q 10 biosynthesis by lipid-lowering HMG- CoA reductase inhibitors (statins): A critical overview
    • Bliznakov EG, Wilkins DJ. Biochemical and clinical consequences of inhibiting coenzyme Q 10 biosynthesis by lipid-lowering HMG- CoA reductase inhibitors (statins): A critical overview. Adv Therap. 1998; 15:213-228.
    • (1998) Adv Therap , vol.15 , pp. 213-228
    • Bliznakov, E.G.1    Wilkins, D.J.2
  • 78
    • 78650728257 scopus 로고    scopus 로고
    • Ubiquinone - pathophysiology and present role in heart disease
    • American Dietetic Association Medical Nutrition Practice Group
    • Kones R. Ubiquinone - pathophysiology and present role in heart disease. Medical Nutrition Matters. (American Dietetic Association Medical Nutrition Practice Group). 2009;29:5-18.
    • (2009) Medical Nutrition Matters , vol.29 , pp. 5-18
    • Kones, R.1
  • 79
    • 3042706246 scopus 로고    scopus 로고
    • Regulation of ceramide signaling by plasma membrane coenzyme Q reductases
    • Navas P, Villalba JM. Regulation of ceramide signaling by plasma membrane coenzyme Q reductases. Methods Enzymol. 2004;378: 200-206.
    • (2004) Methods Enzymol , vol.378 , pp. 200-206
    • Navas, P.1    Villalba, J.M.2
  • 80
    • 0025979077 scopus 로고
    • Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol
    • Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci U S A. 1991;88: 1646-1650.
    • (1991) Proc Natl Acad Sci U S A , vol.88 , pp. 1646-1650
    • Stocker, R.1    Bowry, V.W.2    Frei, B.3
  • 81
    • 33745410626 scopus 로고    scopus 로고
    • Mitochondrial disease
    • Schapira AH. Mitochondrial disease. Lancet. 2006;368:70-82.
    • (2006) Lancet , vol.368 , pp. 70-82
    • Schapira, A.H.1
  • 82
    • 0031895005 scopus 로고    scopus 로고
    • Mechanisms of MPTP toxicity
    • Prezedborski S, Jackson-Lewis V. Mechanisms of MPTP toxicity. Mov Disord. 1998;13 Suppl 1:35-38.
    • (1998) Mov Disord , vol.13 , Issue.SUPPL. 1 , pp. 35-38
    • Prezedborski, S.1    Jackson-Lewis, V.2
  • 83
    • 0035341492 scopus 로고    scopus 로고
    • Parkinson's disease, pesticides and mitochondrial dysfunction
    • Jenner P. Parkinson's disease, pesticides and mitochondrial dysfunction. Trends Neurosci. 2001;24:245-247.
    • (2001) Trends Neurosci , vol.24 , pp. 245-247
    • Jenner, P.1
  • 84
    • 0036470165 scopus 로고    scopus 로고
    • Distinct role of microglia in rotenone-induced degeneration of dopaminergic neurons
    • Gao HM, Hong JS, Zhang W, Liu B. Distinct role of microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci. 2002;22:782-790.
    • (2002) J Neurosci , vol.22 , pp. 782-790
    • Gao, H.M.1    Hong, J.S.2    Zhang, W.3    Liu, B.4
  • 86
    • 0029050583 scopus 로고
    • Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease
    • Haas RH, Nasirian F, Nakano K, et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease. Ann Neurol. 1995;37:714-722.
    • (1995) Ann Neurol , vol.37 , pp. 714-722
    • Haas, R.H.1    Nasirian, F.2    Nakano, K.3
  • 87
    • 0025640845 scopus 로고
    • Anatomic disease specificity of NADH CoQ1 reductase complex I deficiency in Parkinson's disease
    • Schapira AH, Mann VM, Cooper JM, et al. Anatomic disease specificity of NADH CoQ1 reductase complex I deficiency in Parkinson's disease. J Neurochem. 1990;5:2142-2145.
    • (1990) J Neurochem , vol.5 , pp. 2142-2145
    • Schapira, A.H.1    Mann, V.M.2    Cooper, J.M.3
  • 88
    • 33646369394 scopus 로고    scopus 로고
    • mtDNA clock runs out for dopaminergic neurons
    • Manfredi G. mtDNA clock runs out for dopaminergic neurons. Nat Genet. 2006;38:507-508.
    • (2006) Nat Genet , vol.38 , pp. 507-508
    • Manfredi, G.1
  • 89
    • 0030612117 scopus 로고    scopus 로고
    • Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects
    • Shults CW, Haas RH, Passov D, Beal MF. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Ann Neurol. 1997; 42:261-264.
    • (1997) Ann Neurol , vol.42 , pp. 261-264
    • Shults, C.W.1    Haas, R.H.2    Passov, D.3    Beal, M.F.4
  • 90
    • 0031594295 scopus 로고    scopus 로고
    • Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice
    • Beal MF, Matthews RT, Tieleman A, Shults CW. Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res. 1998;783:109-114.
    • (1998) Brain Res , vol.783 , pp. 109-114
    • Beal, M.F.1    Matthews, R.T.2    Tieleman, A.3    Shults, C.W.4
  • 91
    • 0026764766 scopus 로고
    • Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration
    • Favit A, Nicoletti F, Scapagnini U, Canonico PL. Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration. J Cereb Blood Flow Metab. 1992;12:638-645.
    • (1992) J Cereb Blood Flow Metab , vol.12 , pp. 638-645
    • Favit, A.1    Nicoletti, F.2    Scapagnini, U.3    Canonico, P.L.4
  • 92
    • 0028173480 scopus 로고
    • Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate
    • Beal MF, Henshaw DR, Jenkins BG, Rosen BR, Schulz JB. Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate. Ann Neurol. 1994;36:882-888.
    • (1994) Ann Neurol , vol.36 , pp. 882-888
    • Beal, M.F.1    Henshaw, D.R.2    Jenkins, B.G.3    Rosen, B.R.4    Schulz, J.B.5
  • 93
    • 20144369335 scopus 로고    scopus 로고
    • Mitochondrial mem- brane depolarization and the selective death of dopaminergic neurons by rotenone: Protective effect of coenzyme Q10
    • Moon Y, Lee KH, Park J-H, Geum D, Kim K. Mitochondrial mem- brane depolarization and the selective death of dopaminergic neurons by rotenone: Protective effect of coenzyme Q10. J Neurochem. 2005; 93:1199-1208.
    • (2005) J Neurochem , vol.93 , pp. 1199-1208
    • Moon, Y.1    Lee, K.H.2    Park, J.-H.3    Geum, D.4    Kim, K.5
  • 94
    • 0346158468 scopus 로고    scopus 로고
    • Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential
    • Menke T, Gille G, Reber F, et al. Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential. Biofactors. 2003;18:65-72.
    • (2003) Biofactors , vol.18 , pp. 65-72
    • Menke, T.1    Gille, G.2    Reber, F.3
  • 95
    • 0038336912 scopus 로고    scopus 로고
    • Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease
    • Horvath TL, Diano S, Leranth C, et al. Coenzyme Q induces nigral mitochondrial uncoupling and prevents dopamine cell loss in a primate model of Parkinson's disease. Endocrinology. 2003;44: 2757-2760.
    • (2003) Endocrinology , vol.44 , pp. 2757-2760
    • Horvath, T.L.1    Diano, S.2    Leranth, C.3
  • 96
    • 31444433505 scopus 로고    scopus 로고
    • Parkinson's disease and brain mitochondrial dysfunction: A functional phosphorus magnetic resonance spectroscopy study
    • Rango M, Bonifati C, Bresolin N. Parkinson's disease and brain mitochondrial dysfunction: A functional phosphorus magnetic resonance spectroscopy study. J Cereb Blood Flow Metab. 2006;26: 283-290.
    • (2006) J Cereb Blood Flow Metab , vol.26 , pp. 283-290
    • Rango, M.1    Bonifati, C.2    Bresolin, N.3
  • 97
    • 72649106290 scopus 로고    scopus 로고
    • Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease
    • Hattingen E, Magerkurth J, Pilatus U, et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain. 2009; 132:3285-297.
    • (2009) Brain , vol.132 , pp. 3285-3297
    • Hattingen, E.1    Magerkurth, J.2    Pilatus, U.3
  • 98
    • 0345451597 scopus 로고    scopus 로고
    • Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in Parkinsonian patients
    • Shults CW, Beal MF, Fontaine D, Nakano K, Haas RH. Absorption, tolerability, and effects on mitochondrial activity of oral coenzyme Q10 in Parkinsonian patients. Neurology. 1998;50:793-795.
    • (1998) Neurology , vol.50 , pp. 793-795
    • Shults, C.W.1    Beal, M.F.2    Fontaine, D.3    Nakano, K.4    Haas, R.H.5
  • 99
    • 0036771852 scopus 로고    scopus 로고
    • Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: Evidence for slowing of the functional decline, Phase II
    • Shults CW, Oakes D, Kieburtz K, et al; Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: Evidence for slowing of the functional decline, Phase II. Arch Neurol. 2002;59: 1541-1550.
    • (2002) Arch Neurol , vol.59 , pp. 1541-1550
    • Shults, C.W.1    Oakes, D.2    Kieburtz, K.3
  • 100
    • 33846115045 scopus 로고    scopus 로고
    • A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
    • NINDS NET-PD Investigators
    • NINDS NET-PD Investigators. A randomized clinical trial of coen- zyme Q10 and GPI-1485 in early Parkinson disease. Neurology. 2007; 68:20-28.
    • (2007) Neurology , vol.68 , pp. 20-28
  • 101
  • 102
    • 0032489542 scopus 로고    scopus 로고
    • Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH
    • Seitz G, Gebhardt S, Beck JF, et al. Ascorbic acid stimulates DOPA synthesis and tyrosine hydroxylase gene expression in the human neuroblastoma cell line SK-N-SH. Neurosci Lett. 1998;1: 33-36.
    • (1998) Neurosci Lett , vol.1 , pp. 33-36
    • Seitz, G.1    Gebhardt, S.2    Beck, J.F.3
  • 103
    • 34248182115 scopus 로고    scopus 로고
    • POLANUT Study Group. Nutrient intake in an elderly population in southern France (POLANUT): Deficiency in some vitamins, minerals and omega-3 PUFA
    • Carrière I, Delcourt C, Lacroux A, Gerber M; POLANUT Study Group. Nutrient intake in an elderly population in southern France (POLANUT): Deficiency in some vitamins, minerals and omega-3 PUFA. Int J Vitam Nutr Res. 2007;77:57-65.
    • (2007) Int J Vitam Nutr Res , vol.77 , pp. 57-65
    • Carrière, I.1    Delcourt, C.2    Lacroux, A.3    Gerber, M.4
  • 104
    • 36248932727 scopus 로고    scopus 로고
    • Cognitive performance among the elderly and dietary fish intake: The Hordaland Health Study
    • Nurk E, Drevon CA, Refsum H, et al. Cognitive performance among the elderly and dietary fish intake: The Hordaland Health Study. Am J Clin Nutr. 2007;86:1470-1478.
    • (2007) Am J Clin Nutr , vol.86 , pp. 1470-1478
    • Nurk, E.1    Drevon, C.A.2    Refsum, H.3
  • 105
    • 36249022138 scopus 로고    scopus 로고
    • n-3 Fatty acid proportions in plasma and cognitive performance in older adults
    • Dullemeijer C, Durga J, Brouwer IA, et al. n-3 Fatty acid proportions in plasma and cognitive performance in older adults. Am J Clin Nutr. 2007;86:1479-1485.
    • (2007) Am J Clin Nutr , vol.86 , pp. 1479-1485
    • Dullemeijer, C.1    Durga, J.2    Brouwer, I.A.3
  • 106
    • 36249017462 scopus 로고    scopus 로고
    • Rethinking brain food
    • Rosenberg IH. Rethinking brain food. Am J Clin Nutr. 2007;86: 1259-1260.
    • (2007) Am J Clin Nutr , vol.86 , pp. 1259-1260
    • Rosenberg, I.H.1
  • 110
    • 36249019041 scopus 로고    scopus 로고
    • Prospective study of dietary pattern and risk of Parkinson disease
    • Gao X, Chen H, Fung TT, et al. Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr. 2007;6: 1486-1494.
    • (2007) Am J Clin Nutr , vol.6 , pp. 1486-1494
    • Gao, X.1    Chen, H.2    Fung, T.T.3
  • 111
    • 32044453838 scopus 로고    scopus 로고
    • Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys
    • Samadi P, Grégoire L, Rouillard C, Bédard PJ, Di Paolo T, Lévesque D. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Ann Neurol. 2006;59:282-288.
    • (2006) Ann Neurol , vol.59 , pp. 282-288
    • Samadi, P.1    Grégoire, L.2    Rouillard, C.3    Bédard, P.J.4    Di Paolo, T.5    Lévesque, D.6
  • 112
    • 42049096538 scopus 로고    scopus 로고
    • Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease
    • Bousquet M, Saint-Pierre M, Julien C, Salem NJ, Cicchetti F, Calon F. Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease. FASEB J. 2008;22:1213-1225.
    • (2008) FASEB J , vol.22 , pp. 1213-1225
    • Bousquet, M.1    Saint-Pierre, M.2    Julien, C.3    Salem, N.J.4    Cicchetti, F.5    Calon, F.6
  • 113
    • 47249137372 scopus 로고    scopus 로고
    • Can we prevent Parkinson's disease with n-3 polyunsaturated fatty acids?
    • Calon F, Cicchetti F. Can we prevent Parkinson's disease with n-3 polyunsaturated fatty acids? Future Lipidol. 2008;2:133-137.
    • (2008) Future Lipidol , vol.2 , pp. 133-137
    • Calon, F.1    Cicchetti, F.2
  • 114
    • 0030769660 scopus 로고    scopus 로고
    • Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice
    • Suzuki H, Manabe S, Wada O, Crawford MA. Rapid incorporation of docosahexaenoic acid from dietary sources into brain microsomal, synaptosomal and mitochondrial membranes in adult mice. Int J Vitam Nutr Res. 1997;67:272-278.
    • (1997) Int J Vitam Nutr Res , vol.67 , pp. 272-278
    • Suzuki, H.1    Manabe, S.2    Wada, O.3    Crawford, M.A.4
  • 115
    • 0034571235 scopus 로고    scopus 로고
    • DNA damage in brain mitochondria caused by aging and MPTP treatment
    • Mandavilli BS, Ali SF, Van Houten B. DNA damage in brain mito- chondria caused by aging and MPTP treatment. Brain Res. 2000; 885:45-52.
    • (2000) Brain Res , vol.885 , pp. 45-52
    • Mandavilli, B.S.1    Ali, S.F.2    Van Houten, B.3
  • 116
    • 0026748832 scopus 로고
    • Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells
    • Treen M, Uauy RD, Jameson DM, Thomas VL, Hoffman DR. Effect of docosahexaenoic acid on membrane fluidity and function in intact cultured Y-79 retinoblastoma cells. Arch Biochem Biophys. 1992;294:564-570.
    • (1992) Arch Biochem Biophys , vol.294 , pp. 564-570
    • Treen, M.1    Uauy, R.D.2    Jameson, D.M.3    Thomas, V.L.4    Hoffman, D.R.5
  • 117
    • 33748983343 scopus 로고    scopus 로고
    • Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness
    • McNamara RK, Ostrander M, Abplanalp W, Richtand NM, Benoit SC, Clegg DJ. Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness. Prostaglandins Leukot Essent Fatty Acids. 2006;75:237-257.
    • (2006) Prostaglandins Leukot Essent Fatty Acids , vol.75 , pp. 237-257
    • McNamara, R.K.1    Ostrander, M.2    Abplanalp, W.3    Richtand, N.M.4    Benoit, S.C.5    Clegg, D.J.6
  • 118
    • 34347359673 scopus 로고    scopus 로고
    • Rejuvenation protects neurons in mouse models of Parkinson's disease
    • Chan CS, Guzman JN, Ilijic E, et al. Rejuvenation protects neurons in mouse models of Parkinson's disease. Nature. 2007;447: 1081-1086.
    • (2007) Nature , vol.447 , pp. 1081-1086
    • Chan, C.S.1    Guzman, J.N.2    Ilijic, E.3
  • 119
    • 34547131318 scopus 로고    scopus 로고
    • Novel metabolism of docosahexaenoic acid in neural cells
    • Kim HY. Novel metabolism of docosahexaenoic acid in neural cells. J Biol Chem. 2007;282:18661-18665.
    • (2007) J Biol Chem , vol.282 , pp. 18661-18665
    • Kim, H.Y.1
  • 122
    • 78650750137 scopus 로고    scopus 로고
    • Fish oil protects against diseases like Parkinson's
    • Mar 20, Available at:, Accessed May 14, 2010
    • Bazan N. Fish oil protects against diseases like Parkinson's. Science Daily. Mar 20, 2009. Available at: http://www.sciencedaily.com/releases/2009/04/090419133844.htm. Accessed May 14, 2010.
    • (2009) Science Daily
    • Bazan, N.1
  • 123
    • 61849141189 scopus 로고    scopus 로고
    • for the International Society for the Study of Fatty Acids and Lipids, ISSFAL. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans
    • Brenna JT, Salem N, Sinclair AJ, Cunnane SC; for the International Society for the Study of Fatty Acids and Lipids, ISSFAL. α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot Essent Fatty Acids. 2009;80:85-91.
    • (2009) Prostaglandins Leukot Essent Fatty Acids , vol.80 , pp. 85-91
    • Brenna, J.T.1    Salem, N.2    Sinclair, A.J.3    Cunnane, S.C.4
  • 124
    • 69549103671 scopus 로고    scopus 로고
    • Workshop on DHA as a Required Nutrient: Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA?
    • Rapoport SI, Miki Igarashi M. Workshop on DHA as a Required Nutrient: Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot Essent Fatty Acids. 2009;81:119-123.
    • (2009) Prostaglandins Leukot Essent Fatty Acids , vol.81 , pp. 119-123
    • Rapoport, S.I.1    Miki, I.M.2
  • 126
    • 0030661630 scopus 로고    scopus 로고
    • High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease
    • Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997;49:1273-1278.
    • (1997) Neurology , vol.49 , pp. 1273-1278
    • Sato, Y.1    Kikuyama, M.2    Oizumi, K.3
  • 127
    • 54049152001 scopus 로고    scopus 로고
    • Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease
    • Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65:1348-1352.
    • (2008) Arch Neurol , vol.65 , pp. 1348-1352
    • Evatt, M.L.1    Delong, M.R.2    Khazai, N.3    Rosen, A.4    Triche, S.5    Tangpricha, V.6
  • 128
    • 67650483354 scopus 로고    scopus 로고
    • Association between 25- hydroxyvitamin D levels and cognitive performance in middle-aged and old European men
    • Lee DM, Tajar A, Ulubaev A, et al. Association between 25- hydroxyvitamin D levels and cognitive performance in middle-aged and old European men. J Neurol Neurosurg Psychiatry. 2009;80: 722-729.
    • (2009) J Neurol Neurosurg Psychiatry , vol.80 , pp. 722-729
    • Lee, D.M.1    Tajar, A.2    Ulubaev, A.3
  • 129
    • 74049162336 scopus 로고    scopus 로고
    • 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
    • Buell JS, Dawson-Hughes B, Scott TM, et al. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010;74:18-26.
    • (2010) Neurology , vol.74 , pp. 18-26
    • Buell, J.S.1    Dawson-Hughes, B.2    Scott, T.M.3
  • 130
    • 3843080805 scopus 로고    scopus 로고
    • Mortality in Parkinson's disease and its association with dementia and depression
    • Hughes TA, Ross HF, Mindham RHS, Spokes EGS. Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurol Scand. 2004;110:118-123.
    • (2004) Acta Neurol Scand , vol.110 , pp. 118-123
    • Hughes, T.A.1    Ross, H.F.2    Mindham, R.H.S.3    Spokes, E.G.S.4
  • 131
    • 10744227022 scopus 로고    scopus 로고
    • Body composition in advanced-stage Parkinson's disease
    • Petroni ML, Albani G, Bicchiega V, et al. Body composition in advanced-stage Parkinson's disease. Acta Diabetol. 2003; 40 Suppl 1: 187-190.
    • (2003) Acta Diabetol , vol.40 , Issue.SUPPL. 1 , pp. 187-190
    • Petroni, M.L.1    Albani, G.2    Bicchiega, V.3
  • 132
    • 14844286839 scopus 로고    scopus 로고
    • Recent developments in vitamin D deficiency and muscle weakness among elderly people
    • Venning G. Recent developments in vitamin D deficiency and muscle weakness among elderly people. BMJ. 2005;330:524-526.
    • (2005) BMJ , vol.330 , pp. 524-526
    • Venning, G.1
  • 133
    • 33745603708 scopus 로고    scopus 로고
    • Calcium and vitamin D in the prevention of osteoporotic fractures
    • Francis RM, Anderson FH, Patel S, Sahota O, van Staa TP. Calcium and vitamin D in the prevention of osteoporotic fractures. QJM. 2006; 99:355-363.
    • (2006) QJM , vol.99 , pp. 355-363
    • Francis, R.M.1    Anderson, F.H.2    Patel, S.3    Sahota, O.4    van Staa, T.P.5
  • 134
    • 63849282684 scopus 로고    scopus 로고
    • Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials
    • Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Arch Intern Med. 2009; 169:551-561.
    • (2009) Arch Intern Med , vol.169 , pp. 551-561
    • Bischoff-Ferrari, H.A.1    Willett, W.C.2    Wong, J.B.3
  • 135
    • 0346732368 scopus 로고    scopus 로고
    • Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam
    • Visser M, Deeg JH Dorly, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766-5772.
    • (2003) J Clin Endocrinol Metab , vol.88 , pp. 5766-5772
    • Visser, M.1    Dorly, D.J.H.2    Lips, P.3
  • 136
    • 34347243589 scopus 로고    scopus 로고
    • Vitamin D status predicts physical performance and its decline in older persons
    • Wicherts IS, van Schoor NM, Boeke AJP, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058-2065
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 2058-2065
    • Wicherts, I.S.1    van Schoor, N.M.2    Boeke, A.J.P.3
  • 137
    • 34347209984 scopus 로고    scopus 로고
    • Vitamin D and rehabilitation: Improving functional outcomes
    • Shinchuk L, Holick MF. Vitamin D and rehabilitation: Improving functional outcomes. Nutr Clin Pract. 2007;22:297-304.
    • (2007) Nutr Clin Pract , vol.22 , pp. 297-304
    • Shinchuk, L.1    Holick, M.F.2
  • 138
    • 0034044413 scopus 로고    scopus 로고
    • Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement
    • Glerup H, Mikkelsen K, Poulsen L, et al. Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int. 2000;6:419-424.
    • (2000) Calcif Tissue Int , vol.6 , pp. 419-424
    • Glerup, H.1    Mikkelsen, K.2    Poulsen, L.3
  • 139
    • 33846569956 scopus 로고    scopus 로고
    • A higher dose of vitamin D reduces the risk of falls in nursing home residents: A randomized, multiple-dose study
    • Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick MF, Kiel DP. A higher dose of vitamin D reduces the risk of falls in nursing home residents: A randomized, multiple-dose study. J Am Geriatr Soc. 2007;55:234-239.
    • (2007) J Am Geriatr Soc , vol.55 , pp. 234-239
    • Broe, K.E.1    Chen, T.C.2    Weinberg, J.3    Bischoff-Ferrari, H.A.4    Holick, M.F.5    Kiel, D.P.6
  • 140
    • 38349019697 scopus 로고    scopus 로고
    • Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women
    • Prince RL, Austin N, Devine A, Dick IM, Bruce D, Zhu K. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med. 2008;168:103-108.
    • (2008) Arch Intern Med , vol.168 , pp. 103-108
    • Prince, R.L.1    Austin, N.2    Devine, A.3    Dick, I.M.4    Bruce, D.5    Zhu, K.6
  • 141
    • 63649139745 scopus 로고    scopus 로고
    • Long-term effects of giving nursing home residents bread fortified with 125 micrograms (5000 IU) vitamin D3 per daily serving
    • Mocanu V, Stitt PA, Costan AR, et al. Long-term effects of giving nursing home residents bread fortified with 125 micrograms (5000 IU) vitamin D3 per daily serving. Am J Clin Nutr. 2009;89:1132-1137.
    • (2009) Am J Clin Nutr , vol.89 , pp. 1132-1137
    • Mocanu, V.1    Stitt, P.A.2    Costan, A.R.3
  • 142
    • 34247187985 scopus 로고    scopus 로고
    • Vitamin D and Parkinson's disease: A hypothesis
    • Newmark HL, Newmark J. Vitamin D and Parkinson's disease: a hypothesis. Mov Disord. 2007;22(4):461-468.
    • (2007) Mov Disord , vol.22 , Issue.4 , pp. 461-468
    • Newmark, H.L.1    Newmark, J.2
  • 144
    • 77955047827 scopus 로고    scopus 로고
    • Beyond Vitamin Status Is There a Role for Vitamin D in Parkinson Disease?
    • Evatt ML. Beyond Vitamin Status Is There a Role for Vitamin D in Parkinson Disease? Arch Neurol. 2010;67(7):795-797.
    • (2010) Arch Neurol , vol.67 , Issue.7 , pp. 795-797
    • Evatt, M.L.1
  • 145
    • 52649121742 scopus 로고    scopus 로고
    • Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention
    • Haussler MR, Haussler CA, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(Suppl2):S98-S112.
    • (2008) Nutr Rev , vol.66 , Issue.SUPPL. 2
    • Haussler, M.R.1    Haussler, C.A.2    Bartik, L.3
  • 146
    • 10044272155 scopus 로고    scopus 로고
    • Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain
    • Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30.
    • (2005) J Chem Neuroanat , vol.29 , Issue.1 , pp. 21-30
    • Eyles, D.W.1    Smith, S.2    Kinobe, R.3    Hewison, M.4    McGrath, J.J.5
  • 147
    • 77954600272 scopus 로고    scopus 로고
    • Vitamin D and risk of cognitive decline in elderly persons
    • Llewellyn DJ, Lang IA, Langa KM, et al. Vitamin D and risk of cognitive decline in elderly persons. Arch Int Med. 2010;170(13); 1135-1141.
    • (2010) Arch Int Med , vol.170 , Issue.13 , pp. 1135-1141
    • Llewellyn, D.J.1    Lang, I.A.2    Langa, K.M.3
  • 148
    • 56049118465 scopus 로고    scopus 로고
    • Vitamin D and neurocognitive dysfunction: Preventing Decline?
    • Buell JS, Dawson-Hughes B. Vitamin D and neurocognitive dys- function: preventing Decline? Mol Aspects Med. 2008;29(6): 415-422.
    • (2008) Mol Aspects Med , vol.29 , Issue.6 , pp. 415-422
    • Buell, J.S.1    Dawson-Hughes, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.